Click here to view the CareFirst BCBS Blue Cross Blue Shield Medical Policy Updates »…
Blue Shield California Medical Policy Updates – December 2022
Click here to view the Blue Shield California Medical Policy Updates »
December 2022 Blue Shield California Medical Policy Updates:
- Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer
- Bioengineered Skin and Soft Tissue Substitutes
- Comprehensive Genomic Profiling for Selecting Targeted Cancer Therapies
- Cranial Electrotherapy Stimulation and Auricular Electrostimulation
- Elective Invasive Coronary Angiography (ICA)
- Elective Percutaneous Coronary Intervention (PCI)
- Endovascular Procedures for Intracranial Arterial Disease
- Evaluation of Biomarkers for Alzheimer Disease
- Genetic Cancer Susceptibility Panels Using Next-Generation Sequencing
- Genetic Testing for Alzheimer Disease
- Genetic Testing for BRCA1 or BRCA2 for Heredity Breast/Ovarian Cancer Syndrome and Other High-Risk Cancers
- Genetic Testing for Cardiac Ion Channelopathies
- Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies
- Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes
- Genetic Testing for Mitochondrial Disorders
- Genetic Testing for Predisposition to Inherited Hypertrophic Cardiomyopathy
- Genetic Testing: Exome and Genome Sequencing For The Diagnosis Of Genetic Disorders
- Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Breast Cancer
- Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Ovarian Cancer
- Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Prostate Cancer
- Germline Genetic Testing for Gene Variants Associated With Breast Cancer in Individuals at High Breast Cancer Risk (CHEK2, ATM, and BARD1)
- Germline Genetic Testing for Pancreatic Cancer Susceptibility Genes
- Hysterectomy Surgery for Benign Conditions
- Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
- Knee Arthroplasty for Adults
- Knee Arthroscopy in Knee Osteoarthritis
- Laboratory Tests for Heart and Kidney Transplant Rejection
- Magnetic Resonance Spectroscopy
- Quantitative Electroencephalography as a Diagnostic Aid for Attention-Deficit/Hyperactivity Disorder
- Radiofrequency Ablation of the Renal Sympathetic Nerves as a Treatment for Resistant Hypertension
- Selected Positron Emission Tomography Technologies for Evaluation of Alzheimer Disease
- Total Hip Arthroplasty for Adults
- Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric/Neurologic Disorders
Click here to view the Blue Shield California Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
